216 related articles for article (PubMed ID: 21451111)
41. Retinoic acid alleviates Con A-induced hepatitis and differentially regulates effector production in NKT cells.
Lee KA; Song YC; Kim GY; Choi G; Lee YS; Lee JM; Kang CY
Eur J Immunol; 2012 Jul; 42(7):1685-94. PubMed ID: 22585464
[TBL] [Abstract][Full Text] [Related]
42. Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function.
Rao P; Pham HT; Kulkarni A; Yang Y; Liu X; Knipe DM; Cresswell P; Yuan W
J Virol; 2011 Aug; 85(16):8093-104. PubMed ID: 21653669
[TBL] [Abstract][Full Text] [Related]
43. Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules.
Chen X; Wang X; Keaton JM; Reddington F; Illarionov PA; Besra GS; Gumperz JE
J Immunol; 2007 May; 178(10):6181-90. PubMed ID: 17475845
[TBL] [Abstract][Full Text] [Related]
44. Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells.
Zeissig S; Blumberg RS
Ann N Y Acad Sci; 2012 Feb; 1250():14-24. PubMed ID: 22276638
[TBL] [Abstract][Full Text] [Related]
45. Activation-induced expression of CD1d antigen on mature T cells.
Salamone MC; Rabinovich GA; Mendiguren AK; Salamone GV; Fainboim L
J Leukoc Biol; 2001 Feb; 69(2):207-14. PubMed ID: 11272270
[TBL] [Abstract][Full Text] [Related]
46. Interactions between B-lymphocytes and type 1 NKT cells in autoimmune diabetes.
Dufour FD; Silveira PA; Baxter AG
J Immunotoxicol; 2008 Apr; 5(2):249-57. PubMed ID: 18569396
[TBL] [Abstract][Full Text] [Related]
47. Reduction of CD1d expression in vivo minimally affects NKT-enhanced antibody production but boosts B-cell memory.
Lang GA; Johnson AM; Devera TS; Joshi SK; Lang ML
Int Immunol; 2011 Apr; 23(4):251-60. PubMed ID: 21398691
[TBL] [Abstract][Full Text] [Related]
48. Interview: glycolipid antigen presentation by CD1d and the therapeutic potential of NKT cell activation.
Kronenberg M
J Vis Exp; 2007; (10):635. PubMed ID: 18989407
[TBL] [Abstract][Full Text] [Related]
49. Modulation of antigen presentation and B cell receptor signaling in B cells of beige mice.
Chatterjee P; Tiwari RK; Rath S; Bal V; George A
J Immunol; 2012 Mar; 188(6):2695-702. PubMed ID: 22327079
[TBL] [Abstract][Full Text] [Related]
50. Mycobacterium tuberculosis regulates CD1 antigen presentation pathways through TLR-2.
Roura-Mir C; Wang L; Cheng TY; Matsunaga I; Dascher CC; Peng SL; Fenton MJ; Kirschning C; Moody DB
J Immunol; 2005 Aug; 175(3):1758-66. PubMed ID: 16034117
[TBL] [Abstract][Full Text] [Related]
51. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
[TBL] [Abstract][Full Text] [Related]
52. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes.
Wei DG; Lee H; Park SH; Beaudoin L; Teyton L; Lehuen A; Bendelac A
J Exp Med; 2005 Jul; 202(2):239-48. PubMed ID: 16027237
[TBL] [Abstract][Full Text] [Related]
53. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
Amanuma R; Nakajima T; Yoshie H; Yamazaki K
J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
[TBL] [Abstract][Full Text] [Related]
54. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation.
Sköld M; Xiong X; Illarionov PA; Besra GS; Behar SM
J Immunol; 2005 Sep; 175(6):3584-93. PubMed ID: 16148102
[TBL] [Abstract][Full Text] [Related]
55. Role and regulation of CD1d in normal and pathological B cells.
Chaudhry MS; Karadimitris A
J Immunol; 2014 Nov; 193(10):4761-8. PubMed ID: 25381357
[TBL] [Abstract][Full Text] [Related]
56. CD40L-null NKT cells provide B cell help for specific antibody responses.
Shah HB; Joshi SK; Lang ML
Vaccine; 2011 Nov; 29(49):9132-6. PubMed ID: 21959330
[TBL] [Abstract][Full Text] [Related]
57. Bcl-xL regulates CD1d-mediated antigen presentation to NKT cells by altering CD1d trafficking through the endocytic pathway.
Subrahmanyam PB; Carey GB; Webb TJ
J Immunol; 2014 Sep; 193(5):2096-105. PubMed ID: 25070854
[TBL] [Abstract][Full Text] [Related]
58. Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells.
Li C; Song B; Santos PM; Butterfield LH
Cell Immunol; 2019 Jan; 335():59-67. PubMed ID: 30392891
[TBL] [Abstract][Full Text] [Related]
59. The importance of B cell CD1d expression for humoral immunity.
Lang ML
Expert Rev Vaccines; 2014 Nov; 13(11):1275-8. PubMed ID: 24946838
[TBL] [Abstract][Full Text] [Related]
60. MiR-381-3p Regulates the Antigen-Presenting Capability of Dendritic Cells and Represses Antituberculosis Cellular Immune Responses by Targeting CD1c.
Wen Q; Zhou C; Xiong W; Su J; He J; Zhang S; Du X; Liu S; Wang J; Ma L
J Immunol; 2016 Jul; 197(2):580-9. PubMed ID: 27296666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
